Craig C. Hopkinson - Feb 16, 2022 Form 4 Insider Report for Alkermes plc. (ALKS)

Role: EVP R&D, Chief Medical Officer
Signature: /s/ Stephanie Roche, attorney-in-fact for Craig C. Hopkinson
Stock symbol: ALKS
Transactions as of: Feb 16, 2022
Transactions value $: -$28,639
Form type: 4
Date filed: 2/17/2022, 03:24 PM
Previous filing: Sep 16, 2021
Next filing: Feb 23, 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ALKS	Ordinary Shares	Options Exercise		+3.38K	+35.54%		12.9K	Feb 16, 2022	Direct	F1
transaction	ALKS	Ordinary Shares	Tax liability	-$28.6K	-1.07K	-8.31%	$26.79	11.8K	Feb 16, 2022	Direct

Showing 1 to 2 of 2 entries

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ALKS	Restricted Stock Unit Award	Options Exercise		-3.38K	-100%		0	Feb 16, 2022	Ordinary Shares	3.38K	$0.00	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units convert into ordinary shares on a one-for-one basis.
F2	This award is fully vested in accordance with its terms.